MX2015010174A - Herramientas de diagnostico para predecir la presentacion de preeclampsia. - Google Patents
Herramientas de diagnostico para predecir la presentacion de preeclampsia.Info
- Publication number
- MX2015010174A MX2015010174A MX2015010174A MX2015010174A MX2015010174A MX 2015010174 A MX2015010174 A MX 2015010174A MX 2015010174 A MX2015010174 A MX 2015010174A MX 2015010174 A MX2015010174 A MX 2015010174A MX 2015010174 A MX2015010174 A MX 2015010174A
- Authority
- MX
- Mexico
- Prior art keywords
- preeclampsia
- diagnostic tools
- predict onset
- onset
- predict
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/11—Aminopeptidases (3.4.11)
- C12Y304/11003—Cystinyl aminopeptidase (3.4.11.3)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
Se describen ensayos, kits, métodos, y dispositivos para diagnosticar o predecir la probabilidad de ocurrencia de preeclampsia en una paciente.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361762831P | 2013-02-08 | 2013-02-08 | |
US201361762830P | 2013-02-08 | 2013-02-08 | |
US201361906074P | 2013-11-19 | 2013-11-19 | |
PCT/US2014/015627 WO2014124392A1 (en) | 2013-02-08 | 2014-02-10 | Diagnostic tools to predict onset of preeclampsia |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015010174A true MX2015010174A (es) | 2016-03-31 |
Family
ID=51300184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015010174A MX2015010174A (es) | 2013-02-08 | 2014-02-10 | Herramientas de diagnostico para predecir la presentacion de preeclampsia. |
Country Status (8)
Country | Link |
---|---|
US (3) | US20150377876A1 (es) |
EP (1) | EP2954324B1 (es) |
JP (1) | JP2016507753A (es) |
KR (1) | KR20150119009A (es) |
CN (1) | CN105308456A (es) |
CA (1) | CA2900366A1 (es) |
MX (1) | MX2015010174A (es) |
WO (2) | WO2014124396A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107636466B (zh) * | 2015-02-18 | 2020-07-21 | 阿斯顿大学 | 先兆子痫的诊断性测定和治疗 |
PT3322985T (pt) | 2015-07-15 | 2022-01-13 | Gestvision Inc | Dispositivo para detetar proteínas mal dobradas e seus métodos de uso |
WO2017062270A1 (en) * | 2015-10-05 | 2017-04-13 | The Feinstein Institute For Medical Research | Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies |
CA2929810A1 (en) * | 2016-04-29 | 2017-10-29 | University Of Iowa Research Foundation | Improved early prediction of preeclampsia |
CN109891239B (zh) * | 2016-10-24 | 2022-04-05 | 苏州爱尔迪思生物科技有限公司 | 用于提供子痫前期评估和预测早产的方法和试剂盒 |
US20200124612A1 (en) * | 2017-04-11 | 2020-04-23 | University Of Iowa Research Foundation | Detection of predictors of preeclampsia |
JP6895165B2 (ja) * | 2017-06-06 | 2021-06-30 | 知和 松浦 | α1−アンチキモトリプシンを含むバイオマーカー |
CN108152495A (zh) * | 2017-12-27 | 2018-06-12 | 江苏华鸣生物科技有限公司 | 一种检测酪氨酸的胶体金试纸 |
US10844435B1 (en) | 2020-07-17 | 2020-11-24 | Par Pharmaceutical, Inc. | Method to treat hypotension using vasopressin in certain genotypes |
CN112126683A (zh) * | 2020-08-31 | 2020-12-25 | 中山大学 | 用于迟发型子痫前期诊断的标志物 |
WO2023076257A1 (en) * | 2021-10-25 | 2023-05-04 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Methods for diagnosing leptominingeal metastasis |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5733787A (en) | 1996-06-17 | 1998-03-31 | Bayer Corporation | Method for the detection of creatinine |
US6210971B1 (en) | 1999-01-25 | 2001-04-03 | Bayer Corporation | Assay for the detection of creatinine |
US20030121067A1 (en) * | 2001-09-24 | 2003-06-26 | Brennan Thomas J. | V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto |
JP5630936B2 (ja) | 2004-02-09 | 2014-11-26 | ラピッド パトゲン スクリーニング インコーポレイテッドRapid Pathogen Screening Inc. | ヒトの体液中のターゲットを特定することにより疾病を高速に検出する方法 |
MXPA06012510A (es) * | 2004-04-28 | 2006-12-15 | Pfizer | Derivados de 3-heterociclil-4-fenil-triazol como inhibidores del receptor de vasopresina via. |
GB0600916D0 (en) * | 2006-01-17 | 2006-02-22 | Perkinelmer Instr Las Inc | detecting and predicting pre-eclampsia |
DE102006034142A1 (de) * | 2006-07-24 | 2008-01-31 | B.R.A.H.M.S. Aktiengesellschaft | Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden |
EP2139485B1 (en) | 2007-04-11 | 2012-10-17 | BioMarin Pharmaceutical Inc. | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
US20110251094A1 (en) | 2010-04-13 | 2011-10-13 | Pronota N.V. | Biomarkers for hypertensive disorders of pregnancy |
JP5959506B2 (ja) * | 2010-05-14 | 2016-08-02 | ベス イスラエル デアコネス メディカル センター インコーポレイテッド | 妊娠合併症を治療するための体外デバイスおよび方法 |
BR112012032406A2 (pt) * | 2010-06-18 | 2016-10-25 | Cezanne S A S | marcadores para o prognóstico e avaliação de risco de hipertensão induzida pela gravidez e pré-eclâmpsia |
EP2649454B1 (en) * | 2010-12-06 | 2018-06-20 | Mycartis N.V. | Biomarkers and parameters for hypertensive disorders of pregnancy |
-
2014
- 2014-02-10 US US14/766,528 patent/US20150377876A1/en not_active Abandoned
- 2014-02-10 WO PCT/US2014/015631 patent/WO2014124396A1/en active Application Filing
- 2014-02-10 WO PCT/US2014/015627 patent/WO2014124392A1/en active Application Filing
- 2014-02-10 KR KR1020157024420A patent/KR20150119009A/ko not_active Application Discontinuation
- 2014-02-10 EP EP14749529.5A patent/EP2954324B1/en active Active
- 2014-02-10 US US14/766,574 patent/US9937182B2/en active Active
- 2014-02-10 JP JP2015557180A patent/JP2016507753A/ja active Pending
- 2014-02-10 CA CA2900366A patent/CA2900366A1/en not_active Abandoned
- 2014-02-10 CN CN201480019578.XA patent/CN105308456A/zh active Pending
- 2014-02-10 MX MX2015010174A patent/MX2015010174A/es unknown
-
2018
- 2018-02-27 US US15/906,844 patent/US20180228806A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20180228806A1 (en) | 2018-08-16 |
WO2014124396A1 (en) | 2014-08-14 |
EP2954324A1 (en) | 2015-12-16 |
CA2900366A1 (en) | 2014-08-14 |
EP2954324B1 (en) | 2019-07-31 |
US9937182B2 (en) | 2018-04-10 |
CN105308456A (zh) | 2016-02-03 |
WO2014124392A1 (en) | 2014-08-14 |
JP2016507753A (ja) | 2016-03-10 |
US20150377876A1 (en) | 2015-12-31 |
KR20150119009A (ko) | 2015-10-23 |
EP2954324A4 (en) | 2017-01-04 |
US20150374698A1 (en) | 2015-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015010174A (es) | Herramientas de diagnostico para predecir la presentacion de preeclampsia. | |
HK1216160A1 (zh) | 執行以試劑為基礎的自動化驗的系統、方法和裝置 | |
MA40325A (fr) | Procédés et compositions pour diagnostiquer, pronostiquer et confirmer une pré-éclampsie. | |
EP2972393A4 (en) | BIOMARKERS AND METHOD FOR PREDICTING PREECLAMPSIA | |
EP2972308A4 (en) | BIOMARKERS AND METHOD FOR PREDICTING AN EARLY BIRTH | |
IN2014CN04326A (es) | ||
GB2515983A (en) | Methods and compositions for providing a preeclampsia assessment | |
EP3176268A4 (en) | Novel biomarker for predicting sensitivity to egfr-targeting agent, and use thereof | |
MX2016001719A (es) | Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular. | |
FI3511422T3 (fi) | Menetelmiä ja koostumuksia endometriooosin diagnosointia, ennustamista ja hoitoa varten | |
EP2694667A4 (en) | METHOD, COMPOSITIONS AND KITS FOR TESTING THE MITOCHONDRY FUNCTION | |
EP2952896A4 (en) | PROCESS FOR REDUCING INCORRECT NEGATIVES IN AN IMMUNOASSAY FOR DETERMINING SPECIMENS DERIVED FROM BIOMEMBRANES | |
GB2532684A (en) | Wellbore operations involving computational methods that produce sag profiles | |
EP3176269A4 (en) | Novel biomarker for predicting sensitivity to met inhibitor, and use thereof | |
EP2962105A4 (en) | METHODS AND REAGENTS FOR DETERMINING ISOMERIC ANALYTES | |
MX2016008045A (es) | Biomarcadores de lipogenesis de novo y metodos de uso de los mismos. | |
HK1204061A1 (en) | Methods and kits for detecting and diagnosing neurotrauma | |
EP3036712A4 (en) | Methods for predicting prognosis | |
MX2015015015A (es) | Metodo para diagnosticar cancer. | |
IL240129B (en) | Methods and kits for determining the risk of getting extrapyramidal symptoms (eps) as a result of treatment with antipsychotics | |
WO2014160237A3 (en) | Methods of prognosing preeclampsia | |
MY156871A (en) | Detection methods for oil palm shell alleles | |
EP2972344A4 (en) | Methods and compositions for diagnosing preeclampsia | |
IL274477A (en) | Biomarker assays for use in autism surveillance | |
PL2759657T3 (pl) | Stanowisko badawcze dla drzwi, okien i elewacji |